Committed to the development of Nuclear Medicine and to the high quality of supply to its customers, IBA is currently deploying an ambitious global investment plan which will reach the strict standards in pharmaceutical & safety regulations. More than 60 millions euros have been dedicated to the upgrade of our manufacturing facilities.